erythrosine has been researched along with fg 9041 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedingfield, JB; Calder, LD; Karler, R | 1 |
Barnstable, CJ; Otori, Y; Wei, JY | 1 |
Hara, H; Yamamoto, R; Yoneda, S | 1 |
Kovacs, FE; Szabo, B; Urbanski, MJ | 1 |
4 other study(ies) available for erythrosine and fg 9041
Article | Year |
---|---|
Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice.
Topics: Amphetamine; Animals; Apomorphine; Cocaine; Diltiazem; Dopamine Agonists; Drug Interactions; Fluoresceins; Male; Mice; Quinoxalines; Stereotyped Behavior | 1996 |
Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells.
Topics: 2-Amino-5-phosphonovalerate; Aniline Compounds; Animals; Calcium; Cell Death; Cell Separation; Cells, Cultured; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoresceins; Fluorescent Dyes; Glutamic Acid; Microscopy, Confocal; Patch-Clamp Techniques; Quinoxalines; Rats; Receptors, AMPA; Retinal Ganglion Cells; Xanthenes | 1998 |
Neuroprotective effects of beta-secretase inhibitors against rat retinal ganglion cell death.
Topics: Amyloid Precursor Protein Secretases; Animals; Animals, Newborn; Cell Count; Cell Death; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fluoresceins; Fluorescent Dyes; Glutamic Acid; Male; Neuroprotective Agents; Oligopeptides; Quinoxalines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Retinal Ganglion Cells | 2004 |
Depolarizing GABAergic synaptic input triggers endocannabinoid-mediated retrograde synaptic signaling.
Topics: Aniline Compounds; Animals; Animals, Newborn; Arachidonic Acids; Benzamides; Bicuculline; Biophysics; Calcium; Calcium Signaling; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Carbamates; Cerebellum; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fluoresceins; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycerides; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Lactones; Mice; Muscimol; Orlistat; Patch-Clamp Techniques; Piperidines; Purkinje Cells; Pyrazoles; Quinoxalines; Rimonabant; Signal Transduction; Synapses; Valine | 2009 |